Fluxion (Diagnostic Equipment) Overview
- Year Founded
-
2005
- Status
-
Acquired/Merged
- Employees
-
13
- Latest Deal Type
-
M&A
- Investors
-
1
Fluxion (Diagnostic Equipment) General Information
Description
Developer of live cell analysis tools designed to facilitate the transformation of complex cell-based assays. The company's tools offer disease research, drug discovery, and the development of diagnostic tests in the fields of liquid biopsy, oncology, ion channels, hematology, immunology, and microbiology, enabling healthcare professionals to carry out efficient diagnoses and analyses.
Contact Information
Website
www.fluxionbio.com(Operating Subsidiary)
Corporate Office
- 1901 Poplar Street
- Suite B
- Alameda, CA 94607
- United States
Corporate Office
- 1901 Poplar Street
- Suite B
- Alameda, CA 94607
- United States
Fluxion (Diagnostic Equipment) Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 16. Merger/Acquisition | 23-Aug-2023 | Completed | Generating Revenue | |||
| 15. Debt - PPP | 15-Apr-2020 | Completed | Generating Revenue | |||
| 14. Accelerator/Incubator | 01-Feb-2020 | Completed | Generating Revenue | |||
| 13. Grant | 15-Sep-2019 | Completed | Generating Revenue | |||
| 12. Grant | 10-Sep-2018 | Completed | Generating Revenue | |||
| 11. Later Stage VC | 18-May-2018 | Completed | Generating Revenue | |||
| 10. Later Stage VC (Series D) | 21-Jan-2016 | Completed | Generating Revenue | |||
| 9. Later Stage VC (Series C1) | 08-Feb-2013 | Completed | Generating Revenue | |||
| 8. Later Stage VC | 01-Oct-2012 | $2M | $25M | Completed | Generating Revenue | |
| 7. Later Stage VC (Series C) | 09-Oct-2011 | $12.7M | $23M | Completed | Generating Revenue |
Fluxion (Diagnostic Equipment) Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series D | ||||||||
| Series C1 | ||||||||
| Series C | ||||||||
| Series B | 9,168,831 | $0.001000 | $0.08 | $1.05 | $1.05 | 1x | $1.05 | 27.11% |
| Series A | 984,608 | $0.001000 | $0.05 | $0.65 | $0.65 | 1x | $0.65 | 2.91% |
Fluxion (Diagnostic Equipment) Comparisons
Industry
Financing
Details
Fluxion (Diagnostic Equipment) Competitors (22)
One of Fluxion (Diagnostic Equipment)’s 22 competitors is Ionpath, a Venture Capital-Backed company based in Menlo Park, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Ionpath | Venture Capital-Backed | Menlo Park, CA | ||||
| LumaCyte | Venture Capital-Backed | Charlottesville, VA | ||||
| RareCyte | Venture Capital-Backed | Seattle, WA | ||||
| Oxford Nanopore Technologies | Formerly VC-backed | Oxford, United Kingdom | ||||
| Nucleix | Venture Capital-Backed | Rehovot, Israel |
Fluxion (Diagnostic Equipment) Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Fluxion (Diagnostic Equipment) Patents
Fluxion (Diagnostic Equipment) Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3513345-A1 | Methods and systems for ultra-sensitive detection of genomic alterations | Inactive | 16-Sep-2016 | ||
| EP-3513345-A4 | Methods and systems for ultra-sensitive detection of genomic alterations | Inactive | 16-Sep-2016 | ||
| US-20170268037-A1 | Methods and systems for cell separation using magnetic-and size-based separation | Inactive | 15-May-2014 | ||
| EP-2731723-A1 | Devices, systems, and methods for magnetic separation | Active | 14-Jul-2011 | ||
| EP-2731723-B1 | Methods for magnetic separation | Inactive | 14-Jul-2011 | C12Q1/6806 |
Fluxion (Diagnostic Equipment) Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Fluxion (Diagnostic Equipment) Former Investors (19)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Angel (individual) | Minority | |||
| Angel (individual) | Minority | |||
| Claremont Creek Ventures | Venture Capital | Minority | ||
| Eunice Kennedy Shriver National Institute of Child Health and Human Development | Government | |||
| Angel (individual) | Minority |
Fluxion (Diagnostic Equipment) FAQs
-
When was Fluxion (Diagnostic Equipment) founded?
Fluxion (Diagnostic Equipment) was founded in 2005.
-
Where is Fluxion (Diagnostic Equipment) headquartered?
Fluxion (Diagnostic Equipment) is headquartered in Alameda, CA.
-
What is the size of Fluxion (Diagnostic Equipment)?
Fluxion (Diagnostic Equipment) has 13 total employees.
-
What industry is Fluxion (Diagnostic Equipment) in?
Fluxion (Diagnostic Equipment)’s primary industry is Diagnostic Equipment.
-
Is Fluxion (Diagnostic Equipment) a private or public company?
Fluxion (Diagnostic Equipment) is a Private company.
-
What is Fluxion (Diagnostic Equipment)’s current revenue?
The current revenue for Fluxion (Diagnostic Equipment) is .
-
How much funding has Fluxion (Diagnostic Equipment) raised over time?
Fluxion (Diagnostic Equipment) has raised $29.1M.
-
Who are Fluxion (Diagnostic Equipment)’s investors?
, , Claremont Creek Ventures, Eunice Kennedy Shriver National Institute of Child Health and Human Development, and are 5 of 19 investors who have invested in Fluxion (Diagnostic Equipment).
-
Who are Fluxion (Diagnostic Equipment)’s competitors?
Ionpath, LumaCyte, RareCyte, Oxford Nanopore Technologies, and Nucleix are some of the 22 competitors of Fluxion (Diagnostic Equipment).
-
When was Fluxion (Diagnostic Equipment) acquired?
Fluxion (Diagnostic Equipment) was acquired on 23-Aug-2023.
-
Who acquired Fluxion (Diagnostic Equipment)?
Fluxion (Diagnostic Equipment) was acquired by Cell Microsystems.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
